Risk prediction model based on blood biomarkers for predicting moderate to severe endoscopic activity in patients with ulcerative colitis

被引:5
|
作者
Li, Xiaojuan [1 ]
Tang, Zihui [2 ]
Liu, Yanbing [2 ]
Zhu, Xinyan [2 ]
Liu, Fei [2 ,3 ]
机构
[1] Fudan Univ, Minhang Hosp, Dept Gastroenterol, Shanghai, Peoples R China
[2] Tongji Univ, Shanghai East Hosp, Dept Gastroenterol, Med Sch, Shanghai, Peoples R China
[3] Jian Hosp, Shanghai East Hosp, Dept Gastroenterol, Jian, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
dynamic nomogram; Lasso regression; ulcerative colitis; endoscopic activity; blood biomarker; DISEASE; OUTCOMES; EVENTS; INDEX;
D O I
10.3389/fmed.2023.1101237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectWe explored developing an internal validation model to predict the moderate to severe endoscopic activity of ulcerative colitis (UC) patients based on non-invasive or minimally-invasive parameters. MethodsUlcerative Colitis Endoscopic Index of Severity (UCEIS) and Mayo endoscopic subscore were performed for UC patients who met the criteria from January 2017 to August 2021 through the electronic database of our center. Logistic regression and a least absolute shrinkage and selection operator (Lasso) regression model were performed to screen the risk factors of moderate to severe UC activity. The nomogram was established subsequently. Discrimination of the model was evaluated using the concordance index (c-index), and the calibration plot and 1,000 Bootstrap were used to evaluate the model's performance and conduct internal validation. ResultsSixty-five UC patients were included in this study. According to UCEIS criteria,45 patients were moderate to severe endoscopic activity. 26 potential predictors of UC were analyzed by logistic and Lasso regression showed that vitamin D (Vit D), albumin (ALB), prealbumin (PAB), and fibrinogen (Fbg) were the best predictors of moderate to severe endoscopic activity of UC. We used these 4 variables to develop a dynamic nomogram prediction model. The c-index was 0.860, which means good discrimination. The calibration plot and Bootstrap analysis showed that the prediction model accurately distinguished the moderate to severe endoscopic activity in UC patients. The prediction model was verified using a cohort of UC patients with moderate to severe activity defined by the Mayo endoscopic subscore, and it was found that the model still had good discrimination and calibration (c-index = 0.891). ConclusionThe model containing Vit D, ALB, PAB, and Fbg was a good tool for evaluating UC activity. The model is simple, accessible, and user-friendly, which has broad application prospects in clinical practice.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Responsiveness of different disease activity indices in moderate-to-severe ulcerative colitis
    Solitano, Virginia
    Panaccione, Remo
    Sands, Bruce E.
    Wang, Zhongya
    Hogan, Malcolm
    Zou, Guangyong
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Cornfield, Linda J.
    Feagan, Brian G.
    Singh, Siddharth
    Jairath, Vipul
    Ma, Christopher
    MED, 2025, 6 (02):
  • [32] Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury
    Anderson, Taylor N.
    Hwang, Jun
    Munar, Myrna
    Papa, Linda
    Hinson, Holly E.
    Vaughan, Allison
    Rowell, Susan E.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2020, 89 (01): : 80 - 86
  • [33] Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis
    Kim, Jong Wook
    Boo, Sun-Jin
    Ye, Byong Duk
    Kim, Chang Lae
    Yang, Suk-Kyun
    Kim, Jihun
    Kim, Sun A.
    Park, Sang Hyoung
    Park, Soo-Kyung
    Yang, Dong-Hoon
    Jung, Kee Wook
    Kim, Kyung-Jo
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Kim, Jin-Ho
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (07): : 693 - 701
  • [34] The clinical utility of CMV antigenemia and blood CMV DNA PCR in the diagnosis of CMV colitis in patients with moderate to severe ulcerative colitis
    Boo, S-J
    Ye, B. D.
    Yang, D-H
    Jung, K. W.
    Kim, K. J.
    Byeon, J-S
    Myung, S-J
    Yang, S-K
    Kim, J-H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 5 - 6
  • [35] A metabolomics-driven model for early remission prediction following vedolizumab treatment in patients with moderate-to-severe active ulcerative colitis
    Jiang, Leilei
    Liu, Xiaoming
    Su, Yue
    Chen, Yujie
    Yang, Shaozhi
    Ke, Xiquan
    Yao, Kunhou
    Guo, Zhiguo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 128
  • [36] Measuring endoscopic activity in patients treated with vedolizumab for ulcerative colitis
    Emont, C.
    Gay, C.
    Parmentier, A. L.
    Koch, S.
    Ambregna, S.
    Claude, G.
    Sage, P.
    Zhong, P.
    Briot, C.
    Vuitton, L.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S455 - S456
  • [37] THE ROLE OF HANDHELD ULTRASONOGRAPHY IN PREDICTING DISEASE EXTENSION AND ENDOSCOPIC ACTIVITY IN ULCERATIVE COLITIS
    Rispo, Antonio
    Calabrese, Giulio
    Testa, Anna
    Imperatore, Nicola
    Patturelli, Marta
    Guarino, Alessia Dalila
    Allocca, Mariangela
    Olmo, Oriana
    Cantisani, Nicola Mattia
    Toro, Benedetta
    Castiglione, Fabiana
    GASTROENTEROLOGY, 2023, 164 (06) : S62 - S62
  • [38] Early prediction of intravenous corticosteroid therapy failure in moderate-severe ulcerative colitis
    Croft, A.
    Lord, A.
    Radford-Smith, G.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S458 - S458
  • [39] MODERATE TO SEVERE ENDOSCOPIC INFLAMMATION IS FREQUENT AFTER ACHIEVING CLINICAL REMISSION IN PEDIATRIC ULCERATIVE COLITIS
    Sarbagili-Shabat, Chen
    Weiner, Dror
    Wardi, Joram
    Abramas, Lee
    Yaakov, Michal
    Levine, Arie
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S13 - S13
  • [40] Moderate-to-severe Endoscopic Inflammation is Frequent After Clinical Remission in Pediatric Ulcerative Colitis
    Sarbagili-Shabat, Chen
    Weiner, Dror
    Wardi, Joram
    Abramas, Lee
    Yaakov, Michal
    Levine, Arie
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 72 (04): : 569 - 573